The Barefoot College in Rajasthan provides sustainable sources of energy at the village level for cooking, lighting and heating. Poor Women from lower castes in India learn to install, repair and maintain parabolic solar cookers, solar lighting units and solar water heaters. With knowledge and training, women untouchables earn a livelihood in their communities as solar engineers.
The Barefoot College helps generate solar energy in rural villages across 16 states in India, providing a path to dignity for poor women.
Sixteen million girls 15 to19 years, and 2 million younger than 15 years, have a high risk of stillbirths, neonatal deaths, preterm births, small-for-gestational-age babies, and complications during birth.
Prevention of child marriage and unwanted births is essential to reduce neonatal and maternal mortality for girls. Sexual and reproductive education with access to secondary school can delay age at birth of the first child, and empower young women to make healthy choices for their wellbeing.
"The dividend will be not only an acceleration of progress towards ending maternal, neonatal, and child mortality, but also a better educated future for a generation of women."
Diarrhoea and respiratory infections are the two biggest causes of child death globally. Handwashing with soap is like a do-it yourself vaccine; a singularly effective preventative measure against disease. Yet, one of the hardest to put into practice.
An intervention at the village level in rural Andra Pradesh applied a model of behavior change based on emotional drivers, rather than knowledge of negative consequences per se. The SuperAmma Campaign included community and school-based events incorporating an animated film, skits, posters and materials with emotional motivators, such as feelings of disgust, nurture, affiliation and status.
An evaluation using RCT methods of the SuperAmma Campaign showed significant improvement in hand washing behavior in the target villages compared to control.
The End of the Developing World
OpEd, New York Times
Ending Newborn Deaths: Ensuring Every Baby Survives
A new report released by Save the Children, aims to accelerate reductions in neonatal mortality.
One half of first day deaths around the world can be prevented if the mother and baby have access to free health care and a skilled midwife.
The most common cause of neonatal deaths is complications of prematurity (34%); intrapartum-related complications (24%); sepsis, meningitis, or pneumonia (22%); and congenital abnormalities (9%). Some countries have made substantial progress, particularly China, Egypt and Cambodia. Progress in Sub-Saharan Africa is slow.
Inequalities within countries can be stark, mirroring economic inequality, lack of social mobility and access to health services. For example, in India, 26 per 1000 livebirths die in the wealthiest quintile; 56 per 1000 die in the poorest.
- Skilled care at birth and emergency obstetric care
- Management of preterm births, including antenatal corticosteroids for lung maturation
- Basic neonatal care, such as general cleanliness, cord care, warmth, immediate breastfeeding, and recognition of danger signs
- Neonatal resuscitation
- Kangaroo Mother Care
- Early identification and antibiotic treatment of serious infections
- Inpatient care for small and sick newborns
- Prevention of mother-to-child transmission of HIV
Click on the Cover image to access Ending Newborn Deaths
Source: The Lancet
Extracted from the plant Artemisia annu, Artemisinin is effective in treating multi-drug resistant strains of malaria. Demand for Artemisinin is growing as pathogens become resistant to earlier anti-malarial medicines.
Trade finance loans to Artemisinin extractors can benefit small holder farmers and help secure the supply chain. Farmers receive advance payments to plant Artemisia annu, and a second payment at harvest and delivery.
Masai smallholder farmers grow Artemisia annu as a cash crop on a contract basis in the hills outside Arusha, Tanzania,
Masai women pulverize dried cuttings.
Workers pack Artemisia powder into bags for storage and truck transport to the extractor facility in Kenya.
Artemisinin is extracted at Botanical Extracts EPZ LTD plant in Kenya, and shipped to pharmaceutical manufacturer Novartis in Switzerland for production of antimalarial medication.
Tanzania and Kenya Images by Susan Meiselas/Magnum